vs
Side-by-side financial comparison of Vita Coco Company, Inc. (COCO) and FORRESTER RESEARCH, INC. (FORR). Click either name above to swap in a different company.
Vita Coco Company, Inc. is the larger business by last-quarter revenue ($179.8M vs $101.1M, roughly 1.8× FORRESTER RESEARCH, INC.). Vita Coco Company, Inc. runs the higher net margin — 17.0% vs -33.5%, a 50.5% gap on every dollar of revenue. On growth, Vita Coco Company, Inc. posted the faster year-over-year revenue change (37.3% vs -6.5%). Over the past eight quarters, Vita Coco Company, Inc.'s revenue compounded faster (11.7% CAGR vs 0.5%).
The Vita Coco Company, doing business simply as Vita Coco, is an American beverage company which mainly sells coconut water. The largest brand globally in coconut/plant waters, Vita Coco has operations in 31 countries as of 2016. It is a benefit corporation. The company is owned by All Market Inc.
Forrester Research, Inc. is a research and advisory firm working in research, consulting and events. Forrester’s clients include large global business, technology and consumer enterprises. The firm is headquartered in Cambridge, MA.
COCO vs FORR — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $179.8M | $101.1M |
| Net Profit | $30.5M | $-33.9M |
| Gross Margin | 39.9% | 56.7% |
| Operating Margin | 18.7% | -36.6% |
| Net Margin | 17.0% | -33.5% |
| Revenue YoY | 37.3% | -6.5% |
| Net Profit YoY | 61.4% | -7941.4% |
| EPS (diluted) | $0.50 | $-1.75 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $179.8M | — | ||
| Q4 25 | $127.8M | $101.1M | ||
| Q3 25 | $182.3M | $94.3M | ||
| Q2 25 | $168.8M | $111.7M | ||
| Q1 25 | $130.9M | $89.9M | ||
| Q4 24 | $127.3M | $108.0M | ||
| Q3 24 | $132.9M | $102.5M | ||
| Q2 24 | $144.1M | $121.8M |
| Q1 26 | $30.5M | — | ||
| Q4 25 | $5.5M | $-33.9M | ||
| Q3 25 | $24.0M | $-2.1M | ||
| Q2 25 | $22.9M | $3.9M | ||
| Q1 25 | $18.9M | $-87.3M | ||
| Q4 24 | $3.4M | $432.0K | ||
| Q3 24 | $19.3M | $-5.8M | ||
| Q2 24 | $19.1M | $6.3M |
| Q1 26 | 39.9% | — | ||
| Q4 25 | 34.9% | 56.7% | ||
| Q3 25 | 37.7% | 60.0% | ||
| Q2 25 | 36.3% | 55.5% | ||
| Q1 25 | 36.7% | 55.9% | ||
| Q4 24 | 32.5% | 58.8% | ||
| Q3 24 | 38.8% | 60.5% | ||
| Q2 24 | 40.8% | 57.3% |
| Q1 26 | 18.7% | — | ||
| Q4 25 | 8.0% | -36.6% | ||
| Q3 25 | 15.3% | 4.7% | ||
| Q2 25 | 14.9% | 6.2% | ||
| Q1 25 | 14.7% | -97.5% | ||
| Q4 24 | 3.4% | -0.5% | ||
| Q3 24 | 15.5% | -0.7% | ||
| Q2 24 | 20.8% | 9.3% |
| Q1 26 | 17.0% | — | ||
| Q4 25 | 4.3% | -33.5% | ||
| Q3 25 | 13.2% | -2.3% | ||
| Q2 25 | 13.6% | 3.5% | ||
| Q1 25 | 14.4% | -97.1% | ||
| Q4 24 | 2.6% | 0.4% | ||
| Q3 24 | 14.5% | -5.7% | ||
| Q2 24 | 13.2% | 5.2% |
| Q1 26 | $0.50 | — | ||
| Q4 25 | $0.10 | $-1.75 | ||
| Q3 25 | $0.40 | $-0.11 | ||
| Q2 25 | $0.38 | $0.20 | ||
| Q1 25 | $0.31 | $-4.62 | ||
| Q4 24 | $0.06 | $0.02 | ||
| Q3 24 | $0.32 | $-0.30 | ||
| Q2 24 | $0.32 | $0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $201.9M | $63.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $352.2M | $126.5M |
| Total Assets | $488.3M | $404.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $201.9M | — | ||
| Q4 25 | $196.9M | $63.3M | ||
| Q3 25 | $203.7M | $65.1M | ||
| Q2 25 | $167.0M | $67.8M | ||
| Q1 25 | $153.6M | $75.6M | ||
| Q4 24 | $164.7M | $56.1M | ||
| Q3 24 | $156.7M | $62.8M | ||
| Q2 24 | $150.1M | $58.9M |
| Q1 26 | $352.2M | — | ||
| Q4 25 | $331.5M | $126.5M | ||
| Q3 25 | $323.7M | $157.7M | ||
| Q2 25 | $296.9M | $159.5M | ||
| Q1 25 | $277.9M | $147.4M | ||
| Q4 24 | $258.8M | $229.5M | ||
| Q3 24 | $252.1M | $234.3M | ||
| Q2 24 | $232.0M | $237.1M |
| Q1 26 | $488.3M | — | ||
| Q4 25 | $461.2M | $404.0M | ||
| Q3 25 | $461.3M | $414.2M | ||
| Q2 25 | $421.1M | $436.0M | ||
| Q1 25 | $384.0M | $439.8M | ||
| Q4 24 | $362.4M | $503.9M | ||
| Q3 24 | $353.1M | $505.3M | ||
| Q2 24 | $323.0M | $524.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-3.2M |
| Free Cash FlowOCF − Capex | — | $-4.3M |
| FCF MarginFCF / Revenue | — | -4.2% |
| Capex IntensityCapex / Revenue | — | 1.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $18.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-3.9M | $-3.2M | ||
| Q3 25 | $39.1M | $1.2M | ||
| Q2 25 | $21.8M | $-3.6M | ||
| Q1 25 | $-9.8M | $26.7M | ||
| Q4 24 | $6.9M | $-1.8M | ||
| Q3 24 | $9.3M | $264.0K | ||
| Q2 24 | $26.9M | $-2.9M |
| Q1 26 | — | — | ||
| Q4 25 | $-7.1M | $-4.3M | ||
| Q3 25 | $35.6M | $524.0K | ||
| Q2 25 | $20.9M | $-4.2M | ||
| Q1 25 | $-10.4M | $26.1M | ||
| Q4 24 | $6.8M | $-2.5M | ||
| Q3 24 | $8.9M | $-223.0K | ||
| Q2 24 | $26.6M | $-3.7M |
| Q1 26 | — | — | ||
| Q4 25 | -5.6% | -4.2% | ||
| Q3 25 | 19.6% | 0.6% | ||
| Q2 25 | 12.4% | -3.8% | ||
| Q1 25 | -7.9% | 29.0% | ||
| Q4 24 | 5.3% | -2.3% | ||
| Q3 24 | 6.7% | -0.2% | ||
| Q2 24 | 18.5% | -3.1% |
| Q1 26 | — | — | ||
| Q4 25 | 2.5% | 1.1% | ||
| Q3 25 | 1.9% | 0.7% | ||
| Q2 25 | 0.6% | 0.5% | ||
| Q1 25 | 0.4% | 0.7% | ||
| Q4 24 | 0.1% | 0.6% | ||
| Q3 24 | 0.3% | 0.5% | ||
| Q2 24 | 0.2% | 0.7% |
| Q1 26 | — | — | ||
| Q4 25 | -0.70× | — | ||
| Q3 25 | 1.63× | — | ||
| Q2 25 | 0.95× | -0.93× | ||
| Q1 25 | -0.52× | — | ||
| Q4 24 | 2.05× | -4.24× | ||
| Q3 24 | 0.48× | — | ||
| Q2 24 | 1.41× | -0.46× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
COCO
| Subtotal | $148.2M | 82% |
| Private Label | $24.4M | 14% |
| Other | $7.2M | 4% |
FORR
| Research Segment | $82.2M | 81% |
| Consulting Segment | $16.2M | 16% |
| Billable Expenses | $1.5M | 2% |
| Professional Services | $1.4M | 1% |
